Mitiperstat (AZD4831)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Mitiperstat (AZD4831), covering 2025-08-29 to 2025-08-29. Get the full timeline:
Most recent: Clinical Trial Update: An Efficacy and Safety Study of Mitiperstat (AZD4831) (MPO Inhibitor) vs Placebo in the Treatment of Moderate to Severe COPD. [Phase 2]